Complementarity in alliance portfolios and firm innovation

Research output: Contribution to journalArticleScientificpeer-review

Abstract

This paper assesses the impact on firm innovation of combining alliance-specific and partner-specific attributes within a firm’s alliance portfolio. In a panel data analysis of the innovation performance of 119 firms operating in the pharmaceutical industry during 1985–2007, we test whether firm’s alliance portfolio displays complementarities across four dimensions. The results suggest that specific combinations of attributes may diminish innovation by decreasing the efficiency of diversity management or by generating redundancies. On the other hand, other alliance portfolio practices are mutually reinforcing and thus foster innovation.
Original languageEnglish
Pages (from-to)633-654
JournalIndustry and Innovation
Volume25
Issue number7
DOIs
Publication statusPublished - 2018

Fingerprint

Innovation
Drug products
Redundancy
Display devices
Alliance portfolios
Complementarity
Industry
Alliances
Panel data analysis
Diversity management
Pharmaceutical industry
Innovation performance

Keywords

  • complementarity
  • alliance portfolio
  • innovation
  • pharmaceutical industry
  • exploration and exploitation

Cite this

@article{411b90e6e0a94fef994e846b4e2b3efe,
title = "Complementarity in alliance portfolios and firm innovation",
abstract = "This paper assesses the impact on firm innovation of combining alliance-specific and partner-specific attributes within a firm’s alliance portfolio. In a panel data analysis of the innovation performance of 119 firms operating in the pharmaceutical industry during 1985–2007, we test whether firm’s alliance portfolio displays complementarities across four dimensions. The results suggest that specific combinations of attributes may diminish innovation by decreasing the efficiency of diversity management or by generating redundancies. On the other hand, other alliance portfolio practices are mutually reinforcing and thus foster innovation.",
keywords = "complementarity, alliance portfolio, innovation, pharmaceutical industry, exploration and exploitation",
author = "Anna Sabidussi and B. Lokshin and Geert Duijsters",
year = "2018",
doi = "10.1080/13662716.2017.1329084",
language = "English",
volume = "25",
pages = "633--654",
journal = "Industry and Innovation",
issn = "1366-2716",
publisher = "ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD",
number = "7",

}

Complementarity in alliance portfolios and firm innovation. / Sabidussi, Anna; Lokshin, B.; Duijsters, Geert.

In: Industry and Innovation, Vol. 25, No. 7, 2018, p. 633-654.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Complementarity in alliance portfolios and firm innovation

AU - Sabidussi, Anna

AU - Lokshin, B.

AU - Duijsters, Geert

PY - 2018

Y1 - 2018

N2 - This paper assesses the impact on firm innovation of combining alliance-specific and partner-specific attributes within a firm’s alliance portfolio. In a panel data analysis of the innovation performance of 119 firms operating in the pharmaceutical industry during 1985–2007, we test whether firm’s alliance portfolio displays complementarities across four dimensions. The results suggest that specific combinations of attributes may diminish innovation by decreasing the efficiency of diversity management or by generating redundancies. On the other hand, other alliance portfolio practices are mutually reinforcing and thus foster innovation.

AB - This paper assesses the impact on firm innovation of combining alliance-specific and partner-specific attributes within a firm’s alliance portfolio. In a panel data analysis of the innovation performance of 119 firms operating in the pharmaceutical industry during 1985–2007, we test whether firm’s alliance portfolio displays complementarities across four dimensions. The results suggest that specific combinations of attributes may diminish innovation by decreasing the efficiency of diversity management or by generating redundancies. On the other hand, other alliance portfolio practices are mutually reinforcing and thus foster innovation.

KW - complementarity

KW - alliance portfolio

KW - innovation

KW - pharmaceutical industry

KW - exploration and exploitation

U2 - 10.1080/13662716.2017.1329084

DO - 10.1080/13662716.2017.1329084

M3 - Article

VL - 25

SP - 633

EP - 654

JO - Industry and Innovation

JF - Industry and Innovation

SN - 1366-2716

IS - 7

ER -